N1VO34 Stock Chart & Stats
$29.89
-$0.52(-1.71%)
―
--
Day’s Range― - ―
52-Week Range$22.90 - $42.43
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
R$1.09T
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.10
Next Earnings
Nov 04, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding3,390,128,000
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Novo Nordisk A/S ADR B Unsponsored Brazilian Depositary Receipt Repr 0.125 ADR B News
N1VO34 FAQ
What was Novo Nordisk A/S ADR B Unsponsored Brazilian Depositary Receipt Repr 0.125 ADR B’s price range in the past 12 months?
Novo Nordisk A/S ADR B Unsponsored Brazilian Depositary Receipt Repr 0.125 ADR B lowest stock price was $22.90 and its highest was $42.43 in the past 12 months.
What is Novo Nordisk A/S ADR B Unsponsored Brazilian Depositary Receipt Repr 0.125 ADR B’s market cap?
Novo Nordisk A/S ADR B Unsponsored Brazilian Depositary Receipt Repr 0.125 ADR B’s market cap is R$1.09T.
When is Novo Nordisk A/S ADR B Unsponsored Brazilian Depositary Receipt Repr 0.125 ADR B’s upcoming earnings report date?
Novo Nordisk A/S ADR B Unsponsored Brazilian Depositary Receipt Repr 0.125 ADR B’s upcoming earnings report date is Nov 04, 2026 which is in 68 days.
How were Novo Nordisk A/S ADR B Unsponsored Brazilian Depositary Receipt Repr 0.125 ADR B’s earnings last quarter?
Currently, no data Available
Is Novo Nordisk A/S ADR B Unsponsored Brazilian Depositary Receipt Repr 0.125 ADR B overvalued?
According to Wall Street analysts Novo Nordisk A/S ADR B Unsponsored Brazilian Depositary Receipt Repr 0.125 ADR B’s price is currently Undervalued.
Does Novo Nordisk A/S ADR B Unsponsored Brazilian Depositary Receipt Repr 0.125 ADR B pay dividends?
Novo Nordisk A/S ADR B Unsponsored Brazilian Depositary Receipt Repr 0.125 ADR B does not currently pay dividends.
What is Novo Nordisk A/S ADR B Unsponsored Brazilian Depositary Receipt Repr 0.125 ADR B’s EPS estimate?
Novo Nordisk A/S ADR B Unsponsored Brazilian Depositary Receipt Repr 0.125 ADR B’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Novo Nordisk A/S ADR B Unsponsored Brazilian Depositary Receipt Repr 0.125 ADR B have?
Novo Nordisk A/S ADR B Unsponsored Brazilian Depositary Receipt Repr 0.125 ADR B has 3,390,128,000 shares outstanding.
What happened to Novo Nordisk A/S ADR B Unsponsored Brazilian Depositary Receipt Repr 0.125 ADR B’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Novo Nordisk A/S ADR B Unsponsored Brazilian Depositary Receipt Repr 0.125 ADR B?
Currently, no hedge funds are holding shares in BR:N1VO34
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Novo Nordisk A/S ADR B Unsponsored Brazilian Depositary Receipt Repr 0.125 ADR B (N1VO34) Earnings & Revenues
AstraZeneca PLC ADR Unsponsored Brazilian Depositary Receipt Repr 0.1666 ADR
―
Abbott Laboratories Shs Unsponsored Brazilian Depository Receipts Repr 0.083333333 S
―
Amgen Inc. Shs Unsponsored Brazilian Depository Receipt Repr 0.03571 Sh
―
Medtronic plc Unsponsored Brazilian Depository Receipt Repr 1/2 Sh
―
Merck & Co., Inc. Shs Unsponsored Brazilian Depository Receipt Repr 0.125 Sh
―